- Home
- WBX vs CMPS Comparison
WBX vs CMPS Comparison
Compare WBX & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WBX | CMPS |
|---|---|---|
| Founded | 2015 | 2020 |
| Country | Spain | United Kingdom |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.2M | 1.9B |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | WBX | CMPS |
|---|---|---|
| Price | $2.87 | $13.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | $4.75 | ★ $25.38 |
| AVG Volume (30 Days) | 12.7K | ★ 2.5M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $18.10 | N/A |
| Revenue Next Year | $94.11 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.30 | $4.88 |
| 52 Week High | $7.83 | $15.87 |
Technical Indicators
Market Signals| Indicator | WBX | CMPS |
|---|---|---|
| Relative Strength Index (RSI) | 41.00 | 41.79 |
| Support Level | $2.64 | $10.96 |
| Resistance Level | $3.12 | $15.11 |
| Average True Range (ATR) | 0.17 | 0.85 |
| MACD | -0.02 | -0.21 |
| Stochastic Oscillator | 5.01 | 4.10 |
Price Performance
Historical ComparisonAbout WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments: Europe, the Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.